A great new article out in @bloodportfolio.bsky.social with lead author Dr. Kline (& featuring many others from our Section including Dr. Smith) doi.org/10.1182/bloo...
and another featuring Dr. Derman in @nature.com www.nature.com/articles/s41...
#AtTheForefront #CancerResearch #OncSky
and another featuring Dr. Derman in @nature.com www.nature.com/articles/s41...
#AtTheForefront #CancerResearch #OncSky
January 30, 2025 at 10:08 PM
A great new article out in @bloodportfolio.bsky.social with lead author Dr. Kline (& featuring many others from our Section including Dr. Smith) doi.org/10.1182/bloo...
and another featuring Dr. Derman in @nature.com www.nature.com/articles/s41...
#AtTheForefront #CancerResearch #OncSky
and another featuring Dr. Derman in @nature.com www.nature.com/articles/s41...
#AtTheForefront #CancerResearch #OncSky
Talking about cancer can be hard and complex. To make it a bit easier, check out our #graphicmedicine series "Explain Cancer to Me" for patient-friendly answers to FAQs: voices.uchicago.edu/communitycan...
#OncSky #MedSky #AtTheForefront #Cancer #PatientEducation
#OncSky #MedSky #AtTheForefront #Cancer #PatientEducation
“Explain Cancer to Me” Comic Series | UCCCC Community Outreach and Engagement
voices.uchicago.edu
November 21, 2024 at 9:18 PM
Talking about cancer can be hard and complex. To make it a bit easier, check out our #graphicmedicine series "Explain Cancer to Me" for patient-friendly answers to FAQs: voices.uchicago.edu/communitycan...
#OncSky #MedSky #AtTheForefront #Cancer #PatientEducation
#OncSky #MedSky #AtTheForefront #Cancer #PatientEducation
It is #PancreaticCancerAwarnessMonth! Learn more about how pancreatic cancer is detected & what early symptoms look like in our latest video on www.tiktok.com/@uchicagocan...
#UniversityofChicago #AtTheForefront #pancreaticcancer #cancerprevention
#UniversityofChicago #AtTheForefront #pancreaticcancer #cancerprevention
UChicagoCancer's Creator Profile
www.tiktok.com
November 25, 2024 at 9:47 PM
It is #PancreaticCancerAwarnessMonth! Learn more about how pancreatic cancer is detected & what early symptoms look like in our latest video on www.tiktok.com/@uchicagocan...
#UniversityofChicago #AtTheForefront #pancreaticcancer #cancerprevention
#UniversityofChicago #AtTheForefront #pancreaticcancer #cancerprevention
March is #ColorectalCancerAwarenessMonth! Make sure you know the best practices for preventing and screening for this cancer:
#AtTheForefront #ColorectalCancer #CancerCare #CancerTreatment #OncSky
#AtTheForefront #ColorectalCancer #CancerCare #CancerTreatment #OncSky
March 3, 2026 at 5:01 PM
March is #ColorectalCancerAwarenessMonth! Make sure you know the best practices for preventing and screening for this cancer:
#AtTheForefront #ColorectalCancer #CancerCare #CancerTreatment #OncSky
#AtTheForefront #ColorectalCancer #CancerCare #CancerTreatment #OncSky
Our Hem/Onc faculty in the media!! Dr. @faubert.bsky.social at the NHL Winter Classic in honor of his #HockeyFightsCancer grant www.nhl.com/news/univers... and Dr. Chen in the ASCO Post talking about her work in HR+/HER2- breast cancer ascopost.com/videos/2024-...
#AtTheForefront #CancerResearch
#AtTheForefront #CancerResearch
Faubert honored at Winter Classic for cancer research | NHL.com
University of Chicago professor receives V Scholar Award for work on lung cancer
www.nhl.com
January 15, 2025 at 8:05 PM
Our Hem/Onc faculty in the media!! Dr. @faubert.bsky.social at the NHL Winter Classic in honor of his #HockeyFightsCancer grant www.nhl.com/news/univers... and Dr. Chen in the ASCO Post talking about her work in HR+/HER2- breast cancer ascopost.com/videos/2024-...
#AtTheForefront #CancerResearch
#AtTheForefront #CancerResearch
March is
🔹🔷 #ColorectalCancerAwarenessMonth 🔷🔹
Join our faculty & staff for some fascinating webinars throughout the month to learn more about where we are with treatment & prevention!
#AtTheForefront #CancerCare #OncSky
🔹🔷 #ColorectalCancerAwarenessMonth 🔷🔹
Join our faculty & staff for some fascinating webinars throughout the month to learn more about where we are with treatment & prevention!
#AtTheForefront #CancerCare #OncSky
March 3, 2025 at 8:03 PM
March is
🔹🔷 #ColorectalCancerAwarenessMonth 🔷🔹
Join our faculty & staff for some fascinating webinars throughout the month to learn more about where we are with treatment & prevention!
#AtTheForefront #CancerCare #OncSky
🔹🔷 #ColorectalCancerAwarenessMonth 🔷🔹
Join our faculty & staff for some fascinating webinars throughout the month to learn more about where we are with treatment & prevention!
#AtTheForefront #CancerCare #OncSky
#TBT to last weekend's South Side Science Festival!! Hosted on campus and open to community members of all ages, we spent the day celebrating science and curiosity!
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
October 10, 2025 at 2:57 PM
#TBT to last weekend's South Side Science Festival!! Hosted on campus and open to community members of all ages, we spent the day celebrating science and curiosity!
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
Congratulations to the UChicago/Infleqtion team who were recently announced as a Phase 1 winner for the NIH Quantum Sensing Technology Challenge!! Learn more about their project at www.challenge.gov?challenge=ni...
@uchicagomedicine.bsky.social
#AtTheForefront
@uchicagomedicine.bsky.social
#AtTheForefront
Challenge.gov
Challenge.gov is the official government website supporting prize challenges and prize competitions that are sponsored by the US federal government. Here federal agencies provide prize awards to publi...
www.challenge.gov
September 11, 2025 at 6:45 PM
Congratulations to the UChicago/Infleqtion team who were recently announced as a Phase 1 winner for the NIH Quantum Sensing Technology Challenge!! Learn more about their project at www.challenge.gov?challenge=ni...
@uchicagomedicine.bsky.social
#AtTheForefront
@uchicagomedicine.bsky.social
#AtTheForefront
TOMORROW!! If you haven't registered yet, there's still time to join our team for Post ASH!
More at www.chicagopostash.com
#AtTheForefront #PostASH #Hematology
More at www.chicagopostash.com
#AtTheForefront #PostASH #Hematology
Post ASH Annual Meeting - Hematology
University of Chicago Post ASH Annual Meeting - American Society of Hematology
www.chicagopostash.com
January 29, 2026 at 10:23 PM
TOMORROW!! If you haven't registered yet, there's still time to join our team for Post ASH!
More at www.chicagopostash.com
#AtTheForefront #PostASH #Hematology
More at www.chicagopostash.com
#AtTheForefront #PostASH #Hematology
Our @uchemoncfellows.bsky.social are doing a superb job presenting their research at today's Hem/Onc Clinical Postdoctoral Fellowship Retreat! Great to hear about their work and fast-building expertise and learn from external speakers!
#AtTheForefront #Oncology #Hematology #ClinicalTraining
#AtTheForefront #Oncology #Hematology #ClinicalTraining
April 7, 2025 at 8:45 PM
Our @uchemoncfellows.bsky.social are doing a superb job presenting their research at today's Hem/Onc Clinical Postdoctoral Fellowship Retreat! Great to hear about their work and fast-building expertise and learn from external speakers!
#AtTheForefront #Oncology #Hematology #ClinicalTraining
#AtTheForefront #Oncology #Hematology #ClinicalTraining
Dr. Rajat Thawani and 2nd year Hem/Onc Fellow Dr. Sulin Wu are co-authors of a new paper in Cancers about the use of tumor-agnostic therapies. Read this great new piece at doi.org/10.3390/canc...
#AtTheForefront #CancerResearch #CancerCare #OncSky
#AtTheForefront #CancerResearch #CancerCare #OncSky
Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives
This review comprehensively analyzes the current landscape of tumor-agnostic therapies in oncology. Tumor-agnostic therapies are designed to target specific molecular alterations rather than the prima...
doi.org
February 28, 2025 at 8:30 PM
Dr. Rajat Thawani and 2nd year Hem/Onc Fellow Dr. Sulin Wu are co-authors of a new paper in Cancers about the use of tumor-agnostic therapies. Read this great new piece at doi.org/10.3390/canc...
#AtTheForefront #CancerResearch #CancerCare #OncSky
#AtTheForefront #CancerResearch #CancerCare #OncSky
Another new article out (‼️) featuring Drs. Garassino, Vokes, and Bestvina (Sr. author) + colleagues about EFGR-mutated NSCLC! Published in Cancer Communications: pmc.ncbi.nlm.nih.gov/articles/PMC...
#AtTheForefront #CancerResearch
#AtTheForefront #CancerResearch
Epigenomic exploration of disease status of EGFR‐mutated non‐small cell lung cancer using plasma cell‐free DNA hydroxymethylomes
pmc.ncbi.nlm.nih.gov
February 20, 2025 at 9:20 PM
Another new article out (‼️) featuring Drs. Garassino, Vokes, and Bestvina (Sr. author) + colleagues about EFGR-mutated NSCLC! Published in Cancer Communications: pmc.ncbi.nlm.nih.gov/articles/PMC...
#AtTheForefront #CancerResearch
#AtTheForefront #CancerResearch
More great context & information from Dr. @ardamanshergill.bsky.social about daraxonrasib for pancreatic cancer featured in Becker's Oncology at www.beckersoncology.com/oncology/the...
#AtTheForefront #PancreaticCancer #CancerCare
#AtTheForefront #PancreaticCancer #CancerCare
'The most significant change in 20 years': Cancer centers prepare for daraxonrasib demand - Becker's Oncology
Health systems across the U.S. have experienced an uptake in patient demand for the pancreatic cancer drug daraxonrasib in the weeks since the FDA granted expanded access to the drug through a May 1 “...
www.beckersoncology.com
June 2, 2026 at 6:44 PM
More great context & information from Dr. @ardamanshergill.bsky.social about daraxonrasib for pancreatic cancer featured in Becker's Oncology at www.beckersoncology.com/oncology/the...
#AtTheForefront #PancreaticCancer #CancerCare
#AtTheForefront #PancreaticCancer #CancerCare
New article alert!! 🚨
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors
Abstract. Purpose:
We present the preclinical rationale and clinical data from a phase 1b trial investigating the STING agonist dazostinag plus pembrolizumab following hypofractionated radiotherapy in...
doi.org
December 2, 2025 at 5:46 PM
New article alert!! 🚨
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
New paper alert 🚨‼️
Our myeloma team and colleagues from across the glob have published their primary analysis of their Phase III ATLAS trial in @thelancet.com! Read it at www.thelancet.com/journals/lan...
#AtTheForefront #Myeloma #ClinicalTrials #CancerResearch #OncSky #MedSky
Our myeloma team and colleagues from across the glob have published their primary analysis of their Phase III ATLAS trial in @thelancet.com! Read it at www.thelancet.com/journals/lan...
#AtTheForefront #Myeloma #ClinicalTrials #CancerResearch #OncSky #MedSky
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis ...
The enhanced efficacy of carfilzomib–lenalidomide–dexamethasone treatment following
autologous HSCT in patients with newly diagnosed multiple myeloma, assessed within
a framework of de-escalation base...
www.thelancet.com
March 13, 2026 at 5:42 PM
New paper alert 🚨‼️
Our myeloma team and colleagues from across the glob have published their primary analysis of their Phase III ATLAS trial in @thelancet.com! Read it at www.thelancet.com/journals/lan...
#AtTheForefront #Myeloma #ClinicalTrials #CancerResearch #OncSky #MedSky
Our myeloma team and colleagues from across the glob have published their primary analysis of their Phase III ATLAS trial in @thelancet.com! Read it at www.thelancet.com/journals/lan...
#AtTheForefront #Myeloma #ClinicalTrials #CancerResearch #OncSky #MedSky
IMPEACHMENT NI VP SARA, WALANG BENEPISYO SA TAUMBAYAN?
Rep. Bonifacio Bosita says the impeachment of VP Sara Duterte would bring no real benefit to the Filipino people if pursued by the Senate, in his exclusive interview with Atty. Karen Jimeno on #AtTheForefront.
Rep. Bonifacio Bosita says the impeachment of VP Sara Duterte would bring no real benefit to the Filipino people if pursued by the Senate, in his exclusive interview with Atty. Karen Jimeno on #AtTheForefront.
February 10, 2025 at 4:56 AM
IMPEACHMENT NI VP SARA, WALANG BENEPISYO SA TAUMBAYAN?
Rep. Bonifacio Bosita says the impeachment of VP Sara Duterte would bring no real benefit to the Filipino people if pursued by the Senate, in his exclusive interview with Atty. Karen Jimeno on #AtTheForefront.
Rep. Bonifacio Bosita says the impeachment of VP Sara Duterte would bring no real benefit to the Filipino people if pursued by the Senate, in his exclusive interview with Atty. Karen Jimeno on #AtTheForefront.
As Atty. Raymond Fortun piles up his celebrated cases, latest of which is the Cyberlibel case filed against Direk Darryl Yap, we'll get to know his real fortune—two young sons, both following their father's footsteps! Live #AtTheForefront with Atty. Karen Jimeno.
January 13, 2025 at 2:58 PM
As Atty. Raymond Fortun piles up his celebrated cases, latest of which is the Cyberlibel case filed against Direk Darryl Yap, we'll get to know his real fortune—two young sons, both following their father's footsteps! Live #AtTheForefront with Atty. Karen Jimeno.
Congratulations to Dr. O'Donnell who is a co-author in a new @nejm.org article about practice-changing findings that resulted in a new FDA approval for bladder cancer! Read it at www.nejm.org/doi/full/10....
#AtTheForefront #CancerCare #CancerResearch #OncSky
#AtTheForefront #CancerCare #CancerResearch #OncSky
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer | NEJM
Patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy proceed directly to radical cystectomy with pelvic lymph-node dissection. Perioperative therapy may ...
www.nejm.org
February 23, 2026 at 10:04 PM
Congratulations to Dr. O'Donnell who is a co-author in a new @nejm.org article about practice-changing findings that resulted in a new FDA approval for bladder cancer! Read it at www.nejm.org/doi/full/10....
#AtTheForefront #CancerCare #CancerResearch #OncSky
#AtTheForefront #CancerCare #CancerResearch #OncSky
Dr. Smith has a new article on @usatoday.com about the importance of survivorship care for those who have had cancer, especially as research and care innovations have improved survival rates and longevity! Read her insights: www.usatoday.com/story/opinio...
#AtTheForefront #CancerCare
#AtTheForefront #CancerCare
People live longer with cancer. That's good news, but ... | Opinion
Better treatment and earlier diagnosis mean that 7 in 10 people will survive five years or more after a cancer diagnosis.
www.usatoday.com
January 29, 2026 at 11:10 PM
Dr. Smith has a new article on @usatoday.com about the importance of survivorship care for those who have had cancer, especially as research and care innovations have improved survival rates and longevity! Read her insights: www.usatoday.com/story/opinio...
#AtTheForefront #CancerCare
#AtTheForefront #CancerCare
What a week for new publications! Dr. Park has a new paper out in @cellpress.bsky.social Immunity about T cells! Read it at www.cell.com/immunity/ful...
#AtTheForefront #CancerImmunity #Tcells #OncSky
#AtTheForefront #CancerImmunity #Tcells #OncSky
Fermenting T cell stemness for cancer immunity
Gut microbial metabolites modulate immune responses to tumors. In this issue of Immunity,
Bachem et al. demonstrate that microbiota-derived butyrate cooperates with the transcription
factor Foxo1 to p...
www.cell.com
November 13, 2025 at 4:48 PM
What a week for new publications! Dr. Park has a new paper out in @cellpress.bsky.social Immunity about T cells! Read it at www.cell.com/immunity/ful...
#AtTheForefront #CancerImmunity #Tcells #OncSky
#AtTheForefront #CancerImmunity #Tcells #OncSky
A new article on alternative dosing strategies for oral cancer meds is out now from Drs. Wesevich & Ratain! You can find it at: www.sciencedirect.com/science/arti...
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
Potential alternative dosage strategies for patent-protected oral cancer drugs
To identify potential alternative dosage strategies for patent-protected oral oncology drugs that could reduce costs without decreasing efficacy for f…
www.sciencedirect.com
October 31, 2025 at 5:31 PM
A new article on alternative dosing strategies for oral cancer meds is out now from Drs. Wesevich & Ratain! You can find it at: www.sciencedirect.com/science/arti...
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
Our faculty in the media!! 👩⚕️👨⚕️
Dr. Chen is on @abc7chicago.bsky.social talking about #BreastCancerAwarenessMonth (abc7chicago.com/post/chicago...)
and
Dr. Sweis on @onclive.bsky.social sharing about a novel treatment approach to renal cell carcinoma (www.onclive.com/view/dual-bi...)
#AtTheForefront
Dr. Chen is on @abc7chicago.bsky.social talking about #BreastCancerAwarenessMonth (abc7chicago.com/post/chicago...)
and
Dr. Sweis on @onclive.bsky.social sharing about a novel treatment approach to renal cell carcinoma (www.onclive.com/view/dual-bi...)
#AtTheForefront
Our Chicago: Breast Cancer Awareness Month
Breast cancer is the most common cancer in women here in the U.S., second only to skin cancers. For 2025, the American Cancer Society estimates that nearly 317 thousand new cases of invasive breast ca...
abc7chicago.com
October 8, 2025 at 8:28 PM
Our faculty in the media!! 👩⚕️👨⚕️
Dr. Chen is on @abc7chicago.bsky.social talking about #BreastCancerAwarenessMonth (abc7chicago.com/post/chicago...)
and
Dr. Sweis on @onclive.bsky.social sharing about a novel treatment approach to renal cell carcinoma (www.onclive.com/view/dual-bi...)
#AtTheForefront
Dr. Chen is on @abc7chicago.bsky.social talking about #BreastCancerAwarenessMonth (abc7chicago.com/post/chicago...)
and
Dr. Sweis on @onclive.bsky.social sharing about a novel treatment approach to renal cell carcinoma (www.onclive.com/view/dual-bi...)
#AtTheForefront
More great coverage of our cancer work nationally in Kansas!! 🗺️⚕️
@chicagotribune.com : www.chicagotribune.com/2025/08/20/u...
@crainschicago.bsky.social : www.chicagobusiness.com/health-care/...
#AtTheForefront #CancerCare #OncSky
@adventhealth.bsky.social / @uchicagomedicine.bsky.social
@chicagotribune.com : www.chicagotribune.com/2025/08/20/u...
@crainschicago.bsky.social : www.chicagobusiness.com/health-care/...
#AtTheForefront #CancerCare #OncSky
@adventhealth.bsky.social / @uchicagomedicine.bsky.social
UChicago Medicine hopes to expand its cancer care nationwide, announces first affiliation with Kansas hospital
AdventHealth Cancer Institute Shawnee Mission in the Kansas City area will remain an independent entity but align with UChicago Medicine when it comes to standards in clinical care, medical educati…
www.chicagotribune.com
August 25, 2025 at 7:58 PM
More great coverage of our cancer work nationally in Kansas!! 🗺️⚕️
@chicagotribune.com : www.chicagotribune.com/2025/08/20/u...
@crainschicago.bsky.social : www.chicagobusiness.com/health-care/...
#AtTheForefront #CancerCare #OncSky
@adventhealth.bsky.social / @uchicagomedicine.bsky.social
@chicagotribune.com : www.chicagotribune.com/2025/08/20/u...
@crainschicago.bsky.social : www.chicagobusiness.com/health-care/...
#AtTheForefront #CancerCare #OncSky
@adventhealth.bsky.social / @uchicagomedicine.bsky.social
A new Medical Stories segment is out/airing on @pbs.org featuring Dr. @arirosenbergmd.bsky.social & one of his patients (who is a former UChicago employee!!). It's a beautiful episode & definitely worth a watch! You can find it at medicalstories.tv/title/head-a...
#HeadNeckCancer #AtTheForefront
#HeadNeckCancer #AtTheForefront
Head and Neck Cancer | Medical Stories
Mary Pat, an assistant at the University of Chicago, finally learned she had head and neck cancer, she dreaded what would come next.
medicalstories.tv
July 15, 2025 at 2:16 PM
A new Medical Stories segment is out/airing on @pbs.org featuring Dr. @arirosenbergmd.bsky.social & one of his patients (who is a former UChicago employee!!). It's a beautiful episode & definitely worth a watch! You can find it at medicalstories.tv/title/head-a...
#HeadNeckCancer #AtTheForefront
#HeadNeckCancer #AtTheForefront
🚀 Let the countdown to Friday and the Developmental Therapeutics Symposium!! Visit www.uofcdevelopmentaltherapeuticssymposium.org to learn more, see the program schedule, and register!
#DevelopmentalTherapeutics #AtTheForefront #OncSky
#DevelopmentalTherapeutics #AtTheForefront #OncSky
April 28, 2025 at 4:38 PM
🚀 Let the countdown to Friday and the Developmental Therapeutics Symposium!! Visit www.uofcdevelopmentaltherapeuticssymposium.org to learn more, see the program schedule, and register!
#DevelopmentalTherapeutics #AtTheForefront #OncSky
#DevelopmentalTherapeutics #AtTheForefront #OncSky